ProMIS Neurosciences PMN
NASDAQ PMN
$14.51 -0.40 (-2.68%)
As of: Aug 21, 2026 · 3:59 PM EDT

ProMIS Neurosciences (PMN) Capital Expenditures Growth (1y) (2022)

ProMIS Neurosciences (PMN) Capital Expenditures Growth (1y) (2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -22.99%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 9.68%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 1,133.33%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -37.81%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 142.64%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -3.37%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -73.62%
9 Royalty Pharma 27.27 Bn 26.43 Bn - 22,433.30%
10 ProMIS Neurosciences 132.34 Mn 78.87 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2022 -100.89%